BCBrian Chan

Brian Chan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Brian Chan has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Devan Kansagara

    Section of Addiction Medicine, Division of General Internal Medicine and Geriatrics, Oregon Health & Science University, Portland

    6 shared publications
  • P. Todd Korthuis

    Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, United States of America; School of Public Health, Oregon Health & Science University and Portland State University, Portland, OR, United States of America

    6 shared publications
  • Somnath Saha

    4 shared publications
  • Chelsea Ayers

    Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States

    3 shared publications
  • Matthew Mitchell

    Central City Concern, Portland, Oregon

    3 shared publications
  • Meg Devoe

    3 shared publications

Latest Publications

  • Validation of the PREVENT-HF Risk Prediction Equation in US Veterans

    by Rebecca L. Tisdale, Neil M. Kalwani, Jun Fan, Valerie McDonald, Evan F. Shalen, Brian Chan, Aradhana Verma, Natasha Din, Anju Sahay, Andrew P. Ambrosy, et al.

  • Open Access

    Race, Ethnicity, and Language Disparities in Alcohol and Drug Screening and Medication Treatment

    by Brian Chan, David Ezekiel-Herrera, Steffani R. Bailey, Elena Byhoff, Miguel Marino, Jennifer A. Lucas, Sophia Giebultowicz, Kevin Espinoza, Zoe Larson, John Heintzman

    Background: Unhealthy alcohol and drug use have significant health-related sequelae. Given racial and ethnic disparities in complications of substance use, successful screening and medication prescribing for addictions are important in community health settings serving diverse populations. Objective: To evaluate alcohol and drug use screening and prescribing of medications for addiction treatment in adults by race, ethnicity, and language preference. Design, Setting, and Participants: This cohort study included US adults seen between 2012 and 2020 in a multistate electronic health record (EHR) network (1394 primary care clinics). Analyses were completed October 2024. Exposure: Race and ethnicity with language preference groups: non-Hispanic White, non-Hispanic Black, Latino with Spanish language preferred, and Latino with English language preferred. Main Outcome(s) and Measures: Multivariable logistic regression estimated covariate-adjusted odds ratios (aOR) of receipt of alcohol and drug screening and EHR-documented prescription of medication for alcohol (AUD) or opioid use disorders (OUD). Results: There were 2 191 945 patients across 25 states (mean (SD) age, 41.3 [15.2] years; 1 236 818 female [56.4%]); 416 607 identified as non-Hispanic Black (19.0%), 1 015 066 non-Hispanic White (46.3%), 474 389 Latino with Spanish-language preference (21.6%), and 285 883 Latino with English-language preference (13.0%). Over the study period, 869 609 (39.7%) had documented completed alcohol screening, and 862 263 (39.3%) completed drug screening—113 629 (5.2%) had a diagnosis of AUD and 247 530 (11.3%) had an OUD diagnosis. Spanish-preferring Latino patients had 59% increased odds of screening compared with non-Hispanic White patients (aOR, 1.59; 95% CI, 1.31-1.93). All minoritized race and ethnicity with language preference groups had lower odds of prescribed medications for addictions treatment compared with non-Hispanic White patients; non-Hispanic Black patients had the lowest odds of any group (AUD: aOR, 0.55; 95% CI, 0.43-0.69; OUD: aOR, 0.38; 95% CI, 0.31-0.46). Conclusions and Relevance: In this cohort study, there was an overall low likelihood of completed screening for alcohol and drug use among all minoritized race and ethnicity with language preference groups. All minoritized groups had lower odds of receipt of medications for addiction treatment compared with the non-Hispanic White group. Improving screening and addressing this emerging treatment inequity should be prioritized.


  • Onsite Primary Care to Address Medical Needs Among Permanent Supportive Housing Tenants: A Feasibility Demonstration Project

    by Brian Redline, John Nusser, Janae Brill, Patrick Brown, Sarah Ichiki, Brian Chan

    Background There is limited evidence on interventions to address the health needs of vulnerable patients in permanent supportive housing (PSH). Aim, Setting, Participants Evaluate the feasibility of Project HOPE, a weekly onsite primary care pilot intervention for tenants of a single-site PSH program. Program Description Physicians, nursing, and pharmacy providers work with existing case managers to provide onsite routine and acute care, outreach, and care coordination. Operations began in November 2020. Program Evaluation Chart review (n = 26) of electronic health records assessed primary care engagement during the 180 days pre- and post-implementation using paired t tests and McNemar’s exact tests, alongside formative observations from site visits and monthly meetings. Compared to the pre period, there was a 50% increase in the proportion of tenants with any primary care engagement (95% CI, 0.24, 0.76), and 84.6% of tenants had at least one visit with Project HOPE. Tenants averaged 2.65 more PCP visits during the post period compared to the pre period (95% CI, 1.60, 3.71). Housing staff perceived improvements in care continuity, chronic disease management, and access to care for tenants. Discussion An onsite primary care delivery model led to increases in primary care engagement for high-acuity PSH tenants.


  • Open Access

    Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis

    by Brian Chan, Ryan Cook, Ximena Levander, Katharina Wiest, Kim Hoffman, Kellie Pertl, Ritwika Petluri, Dennis McCarty, P. Todd Korthuis, Stephen A. Martin


  • Open Access

    Perceptions of Medically Complex Patients Enrolled in an Ambulatory Intensive Care Unit at a Healthcare-for-the-Homeless Clinic

    by Brian Chan, Elizabeth Hulen, Samuel T. Edwards, Anna Geduldig, Meg Devoe, Christina Nicolaidis, P. Todd Korthuis, Somnath Saha

    Background: There is great interest in intensive primary care interventions to address high utilization among medically and socially complex patients. How patients experience these interventions has received less attention. Objective: To better understand patients’ experience of intensive primary care, we interviewed patients receiving care from the Streamlined Unified Meaningfully Managed Interdisciplinary Team (SUMMIT), an ambulatory intensive care intervention at an urban federally qualified health center. Methods: We interviewed 25 participants enrolled in the SUMMIT randomized controlled trial and conducted a Reflective Thematic Analysis using a hybrid inductive-deductive approach. Results: Patients reported high levels of medical and social needs that outstripped prior levels of care and resources. They perceived multiple benefits of SUMMIT through the following themes: 1) Team-based care with improved access to services. Patients appreciated their medical and social needs being met, through higher-level, multidisciplinary care. 2) Caring relationships. Patients described the SUMMIT team as being like family and felt that team members had a genuine sense of duty and obligation toward them. 3) Overcoming stigma. Patients felt valued and treated with dignity. 4) Evolving self-efficacy. Over time, patients experienced increasing success, including engagement in care and improved health behaviors. Conclusion: Patients perceived the SUMMIT team as better meeting their health-related needs, compared with traditional primary care. They spoke of the team as family and felt humanized and supported in overcoming barriers to engagement, which led to increased self-efficacy. Evaluations assessing the effectiveness of intensive primary care should measure potential patient-centered benefits beyond short-term utilization and cost reduction.


  • Open Access

    Ambulatory Intensive Care for Medically Complex Patients at a Health Care Clinic for Individuals Experiencing Homelessness

    by Brian Chan, Samuel T. Edwards, Priya Srikanth, Matthew Mitchell, Meg Devoe, Christina Nicolaidis, Devan Kansagara, P. Todd Korthuis, Rachel Solotaroff, Somnath Saha

    A small number of patients account for a disproportionately large share of health care utilization and costs in the US.1 These patients often face social challenges, including homelessness and poverty, that impose barriers to effectively accessing and using non–acute care services.2 Federally qualified health centers (FQHCs) serve many of these patients. Some FQHCs are designated health care programs for individuals experiencing homelessness and receive additional funds to enhance service delivery (eg, on-site, low-cost pharmacy, and mental health referral and treatment).3 Yet the psychosocial and structural barriers many patients face in accessing services can limit the effectiveness of these programs in reducing acute care utilization.


  • Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs

    by Judith I. Tsui, Bridget M. Whitney, P. Todd Korthuis, Brian Chan, Mai T. Pho, Wiley D. Jenkins, April M. Young, Hannah L.F. Cooper, Peter D. Friedmann, Thomas J. Stopka, et al.


  • Ethnicity, Language, and HIV Screening in Older Adult Safety-Net Patients

    by Jennifer A. Lucas, Miguel Marino, Roopradha Datta, Brian L. Chan, John D. Heintzman


  • Open Access

    Screening for Hepatitis C Among Community Health Center Patients by Ethnicity and Language Preference

    by Brian L. Chan, David Ezekiel-Herrera, Steffani R. Bailey, Miguel Marino, Jennifer A. Lucas, Sophia Giebultowicz, Erika Cottrell, Joe Carroll, John Heintzman


  • Opioid Treatment Programs, Telemedicine and COVID-19: A Scoping Review

    by Brian Chan, Christina Bougatsos, Kelsey C. Priest, Dennis McCarty, Sara Grusing, Roger Chou

    Background: Methadone and buprenorphine are effective medications for opioid use disorder (MOUD) that are highly regulated in the United States. The on-going opioid crisis, and more recently COVID-19, has prompted reconsideration of these restrictions in order to sustain and improve treatment access, with renewed interest in telemedicine. We reviewed the evidence on use of telemedicine interventions and applicability to MOUD policy changes in the post-COVID-19 treatment landscape. Methods: Ovid MEDLINE and the Cochrane Database of Systematic Reviews databases were searched from inception to April 2021 and reference lists were reviewed to identify additional studies. Studies were eligible if they examined telemedicine interventions and reported outcomes (e.g. treatment initiation, retention in care). Randomized trials and controlled observational studies were prioritized; other studies were included when stronger evidence was unavailable. One investigator abstracted key information and a second investigator verified data. We described the results qualitatively. Results: We identified nine studies: three controlled trials (two randomized), and six observational studies. Three studies evaluated patients treated with methadone and six studies with buprenorphine, including one study of pregnant women with OUD. All studies showed telemedicine approaches associated with similar outcomes (treatment retention, positive urine toxicology) compared to treatment as usual. Trials were limited by small samples sizes, lack of reporting harms, and most were conducted prior to the COVID-19 pandemic; observational studies were limited by failure to control for confounding. Conclusions: Limited evidence suggests that telemedicine may enhance access to MOUD with similar effectiveness compared with face-to-face treatment. Few studies have been published since COVID-19, and it is unclear the potential impact of these interventions on the existing racial/ethnic disparities in treatment. The COVID-19 pandemic and need for social distancing led to temporary policy changes for prescribing of MOUD that could inform additional research in this area to support comprehensive policy reforms.